Abstract:Acetaminophen (APAP) overdose still poses a major clinical challenge and is a leading cause of acute liver injury (ALI). N-acetylcysteine (NAC) is the only approved antidote to treat APAP toxicity while NAC therapy can trigger side effects including severe vomiting and even shock. Thus, new insights in developing novel therapeutic drugs may pave the way for better treatment of APAP poisoning. Previous research has reported that nuciferine (Nuci) possesses anti-inflammatory and antioxidant properties. Therefore, the objective of this study was proposed to investigate the hepatoprotective effects of Nuci and explore its underlying mechanisms. Mice were intraperitoneally (i.p.) administered with APAP (300 mg/kg) and subsequently injected with Nuci (25, 50, and 100 mg/kg, i.p.) at 30 min after APAP overdose. Then, all mice were sacrificed at 12 h after APAP challenge for further analysis. Nuci-treated mice did not show any side effects and our results revealed that treating Nuci significantly attenuated APAP-induced ALI, as confirmed by histopathological examinations, biochemical analysis, and diminished hepatic oxidative stress and inflammation. The in silico prediction and mRNA-sequencing analysis were performed to explore the underlying mechanisms of Nuci. GO and KEGG enrichment of the predicted target proteins of Nuci includes reactive oxygen species, drug metabolism of cytochrome P450 (CYP450) enzymes, and autophagy. Furthermore, the mRNA-sequencing analyses indicated that Nuci can regulate glutathione metabolic processes and anti-inflammatory responses. Consistently, we found that Nuci increased the hepatic glutathione restoration but decreased APAP protein adducts in damaged livers. Western blot analysis further confirmed that Nuci effectively promoted hepatic autophagy in APAP-treated mice. However, Nuci could not affect the expression levels of the main CYP450 enzymes (CYP1A2, CYP2E1, and CYP3A11). These results demonstrated that Nuci may be a potential therapeutic drug for APAP-induced ALI via amelioration of the inflammatory response and oxidative stress, regulation of APAP metabolism, and activation of autophagy.

S-nitrosylation attenuates pregnane X receptor hyperactivity and acetaminophen-induced liver injury

Single-cell RNA Sequencing Reveals the Dynamics of Hepatic Non-Parenchymal Cells in Autoprotection Against Acetaminophen-Induced Hepatotoxicity

Pharmacological Inhibition of NADPH Oxidase Protects Against Cisplatin Induced Nephrotoxicity in Mice by Two Step Mechanism

Peroxisome Proliferator-Activated Receptor Γ Coactivator 1α Maintains NAD+ Bioavailability Protecting Against Steatohepatitis

Poly(ADP-ribosyl)ated PXR is a Critical Regulator of Acetaminophen-Induced Hepatotoxicity.

Glutaredoxin-1 Alleviates Acetaminophen-Induced Liver Injury by Decreasing Its Toxic Metabolites

Inhibiting Hepatocyte Uric Acid Synthesis and Reabsorption Ameliorates Acetaminophen-Induced Acute Liver Injury in Mice.

Acetaminophen Responsive Mir-19B Modulates SIRT1/Nrf2 Signaling Pathway in Drug-Induced Hepatotoxicity

Activation of liver X receptor increases acetaminophen clearance and prevents its toxicity in mice.

Disruption of peroxisome proliferator-activated receptor α in hepatocytes protects against acetaminophen-induced liver injury by activating the IL-6/STAT3 pathway

Nuciferine Effectively Protects Mice against Acetaminophen-Induced Liver Injury

Hepatic Hypoxia-Inducible Factors Inhibit PPARα Expression to Exacerbate Acetaminophen Induced Oxidative Stress and Hepatotoxicity

Activation of Farnesoid X Receptor by Schaftoside Ameliorates Acetaminophen-Induced Hepatotoxicity by Modulating Oxidative Stress and Inflammation

P53 Attenuates Acetaminophen-Induced Hepatotoxicity by Regulating Drug-Metabolizing Enzymes and Transporter Expression

SIRT6 As a Key Event Linking P53 and NRF2 Counteracts APAP-induced Hepatotoxicity Through Inhibiting Oxidative Stress and Promoting Hepatocyte Proliferation

Inhibition of NAD Kinase Elevates the Hepatic NAD+ Pool and Alleviates Acetaminophen-Induced Acute Liver Injury in Mice.

Recent advance in the role of peroxisome proliferator-activated receptor α in acetaminophen-induced hepatotoxicity

Activation of pregnane X receptor protects against cholestatic liver injury by inhibiting hepatocyte pyroptosis

Hepato-Protective Effect of Resveratrol Against Acetaminophen-Induced Liver Injury is Associated with Inhibition of Cyp-Mediated Bioactivation and Regulation of Sirt1-P53 Signaling Pathways

Inhibition of p53 Sulfoconjugation Prevents Oxidative Hepatotoxicity and Acute Liver Failure

Nicotinamide Adenine Dinucleotide Attenuates Acetaminophen-Induced Acute Liver Injury Via Activation of PARP1, Sirt1, and Nrf2 in Mice